PSMA-guided surgery for prostate cancer that has spread to lymph nodes
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether using a special imaging tracer during surgery helps find and remove prostate cancer that has spread to lymph nodes, and whether studying immune cells in the removed tissue can predict how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 85 years old.
- You have prostate cancer that has spread to nearby lymph nodes, as shown on a PSMA PET scan.
- You are scheduled to have your prostate removed with robotic surgery, along with lymph node removal.
- You have not had hormonal therapy, chemotherapy, or radiation before this surgery.
- You are able to give written consent and attend all required imaging.
- You do not have cancer that has spread to bones or other organs (like the liver or lungs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special prostate scan called PSMA PET/CT can help doctors decide which pelvic lymph nodes to remove during prostate surgery. It may improve who needs lymph node surgery by using scan results to guide the operation.
This trial is testing whether a special scan (PSMA PET/CT) before surgery can help doctors decide if you need to remove lymph nodes. It is for men with high-risk prostate cancer who are already planning to have robot-assisted prostate removal.
This trial studies whether operating on a small, one-sided (unilateral) area of prostate cancer spread in the pelvic lymph nodes—found on a PSMA PET scan—can help control recurrence. It’s meant for people whose PSA is still low and whose spread appears limited on the scan.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This trial tests a combination of two treatments for men with prostate cancer that has spread to a small number of sites: a radioactive injection (177Lu-PSMA-617) that targets cancer cells, plus hormone-blocking medication. The goal is to control the cancer and delay progression.
This trial tests whether using a combined PSMA-PET/MRI and ultrasound navigation system during robot-assisted prostate removal can help the surgeon remove the cancer more completely while preserving surrounding tissue. It is for patients with early-stage prostate cancer that is just starting to spread outside the prostate.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.